Clinical Study on the Treatment of Glioblastoma Patients with Sonodynamic Therapy Combined with Radiotherapy and Chemotherapy
Year: 2025
Type: article
Study design: Clinical Trial
Abstract: Significance Glioblastoma, has poor prognosis. Sonodynamic therapy (SDT) offers a new non-invasive treatment approach. Approach This clinical trial assesses SDT combined with radiotherapy and chemotherapy. Results Among 19 patients, 68.4% showed stable disease and 15.8% achieved partial remission at six months. Median progression-free survival was 7.6 months, and overall survival was 9.47 months. Conclusions SDT combined with radiotherapy and chemotherapy shows promise in treating glioblastoma, improving survival and symptoms.
Authors: Yingjuan Zheng, Yingjuan Zheng, Linkuan Huangfu, Xiaohao Liu, Pengcheng Zhou, Yahang Liu, Tianqi Liu, Boya Zha, Peihong Li, Haiyang Cui, Yingjuan Zheng, Yingjuan Zheng, Zhifei Dai, Miaomiao Zhang
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,610
OpenAlex ID: W4416390960
FWCI:
Cites:
Cited by:
Related to: